Taiko Pharmaceutical Co (TSE:4574) EV-to-FCF: (As of Jul. 15, 2026)

Taiko Pharmaceutical Co  (TSE:4574) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Taiko Pharmaceutical Co's PE Ratio (TTM) for today is calculated as:

Taiko Pharmaceutical Co's share price for today is 円276.00.
Taiko Pharmaceutical Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was 円10.660.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.

Taiko Pharmaceutical Co EV-to-FCF Related Terms

The historical data trend for Taiko Pharmaceutical Co's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Taiko Pharmaceutical Co EV-to-FCF Chart

Taiko Pharmaceutical Co Annual Data
	Trend	Mar16	Mar17	Mar18	Mar19	Mar20	Dec21	Dec22	Dec23	Dec24	Dec25
EV-to-FCF		Get a 7-Day Free Trial					-10.82	-8.41	-30.65	81.68	22.92

Taiko Pharmaceutical Co Quarterly Data
	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
EV-to-FCF	Get a 7-Day Free Trial															0.00	0.00	0.00	22.92	0.00

TSE:4574 vs ZTS, UTHR: EV-to-FCF Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Taiko Pharmaceutical Co's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Taiko Pharmaceutical Co EV-to-FCF vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Taiko Pharmaceutical Co's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Taiko Pharmaceutical Co's EV-to-FCF falls into.

Taiko Pharmaceutical Co EV-to-FCF Calculation

Taiko Pharmaceutical Co's EV-to-FCF for today is calculated as:

Taiko Pharmaceutical Co's current Enterprise Value is 円10,559 Mil.
Taiko Pharmaceutical Co's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was 円0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Taiko Pharmaceutical Co Business Description